Ignite Creation Date:
2025-12-25 @ 3:33 AM
Ignite Modification Date:
2026-04-24 @ 3:54 AM
Study NCT ID:
NCT03079505
Status:
TERMINATED
Last Update Posted:
2019-01-23
First Post:
2017-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia
Sponsor:
Hamad Medical Corporation
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Myeloid Leukemia - Chronic Phase | View |
Keywords: